Psychometric assessment of EQ-5D-5L and ReQoL measures in patients with anxiety and depression: construct validity and responsiveness
Open Access
- 9 April 2021
- journal article
- research article
- Published by Springer Nature in Quality of Life Research
- Vol. 30 (9) , 2633-2647
Abstract
Purpose: Generic health measures have been questioned for quantifying mental-health-related outcomes. In patients with anxiety and/or depression, our aim is to assess the psychometric properties of the preference-based EQ-5D-5L (generic health) and ReQoL-UI (recovery-focussed quality of life) for economic evaluation against the PHQ-9 (depression) and GAD-7 (anxiety). EQ-5D-5L anxiety/depression item and ReQoL-10 are also assessed. Methods: A 2:1 (intervention: control) randomised controlled trial collected measures at baseline and 8 weeks post baseline; in the intervention arm, data were also collected 3, 6, 9, and 12-months post baseline. EQ-5D-5L preference-based scores were obtained from the value set for England (VSE) and ‘cross-walked’ EQ-5D-3L United Kingdom (UK) value set scores. ReQoL-UI preference-based scores were obtained from its UK value set as applied to seven ReQoL-10 items. EQ-5D-5L and ReQoL measures’ construct validity and responsiveness were assessed compared against PHQ-9 and GAD-7 scores and group cut-offs. Results: 361 people were randomised to intervention (241) or control (120). ReQoL-UI/-10 had better construct validity with depression severity than the EQ-5D-5L (VSE/cross-walk scores), which had relatively better construct validity with anxiety severity than the ReQoL-UI/-10. Across all intervention-arm time-points relative to baseline, responsiveness was generally better for EQ-5D-5L (VSE in particular) than ReQoL-UI, but worse than ReQoL-10. Conclusion: There is insufficient evidence to recommend the ReQoL-UI over EQ-5D-5L for economic evaluations to capture anxiety severity. However, there may be rationale for recommending the ReQoL-UI over the EQ-5D-5L to capture depression severity given its better construct validity, albeit poorer responsiveness, and if recovery-focussed quality of life relative to condition-specific symptomology is the construct of interest.Keywords
Funding Information
- National Institute for Health Research
- SilverCloud Health
This publication has 67 references indexed in Scilit:
- Enhancing recovery rates: Lessons from year one of IAPTBehaviour Research and Therapy, 2013
- Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseasesQuality of Life Research, 2012
- Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country studyQuality of Life Research, 2012
- Implementing NICE guidelines for the psychological treatment of depression and anxiety disorders: The IAPT experienceInternational Review of Psychiatry, 2011
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- A comparison of the EQ‐5D and SF‐6D across seven patient groupsHealth Economics, 2004
- The PHQ-9Journal of General Internal Medicine, 2001
- A power primer.Psychological Bulletin, 1992
- Robust Locally Weighted Regression and Smoothing ScatterplotsJournal of the American Statistical Association, 1979